Clínica Baviera, S.A.
CBAV
Rank in Stocks
#8901
Clínica Baviera, S.A., a healthcare provider, manages a substantial chain of... Clínica Baviera, S.A., a healthcare provider, manages a substantial chain of ophthalmological centers. This organization dedicates itself to the comprehensive diagnosis, therapeutic intervention, and continuous monitoring of diverse ocular conditions. Its facilities offer a wide range of specialized services, addressing issues such as myopia, hyperopia, astigmatism, presbyopia, cataracts, retinal disorders, pediatric eye ailments, glaucoma, strabismus (squint), corneal diseases, neuro-ophthalmology, lacrimal duct problems (vías lagrimales), and oculoplastic procedures. Operating around 90 sites, the company's geographical footprint extends across Spain, Germany, Austria, and Italy. The corporate headquarters are located in Madrid, Spain.
Share Price
$59.26
Last synced: 2026-11-09
Market Cap
$950.00M
Change (1 day)
3.41%
Change (1 year)
26.92%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Clínica Baviera, S.A. (CBAV)
Category
Healthcare
EPS for Clínica Baviera, S.A. (CBAV)
EPS as of June 2026 TTM: $3.11
According to Clínica Baviera, S.A.'s latest financial reports, its current EPS (TTM) is $3.11. At the end of 2025 the company had an EPS of $3.09, an increase over its 2024 EPS of $2.57.
EPS history for Clínica Baviera, S.A. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $3.11 | 0.69% |
| 2025 | $3.09 | 20.06% |
| 2024 | $2.57 | 5.20% |
| 2023 | $2.44 | 25.84% |
| 2022 | $1.94 | 1.63% |
| 2021 | $1.91 | 82.39% |
| 2020 | $1.05 | 19.68% |
| 2019 | $0.88 | 4.33% |
| 2018 | $0.84 | 16.53% |
| 2017 | $0.72 | 39.62% |
| 2016 | $0.52 | 58.31% |
| 2015 | $0.33 | 7.67% |
| 2014 | $0.30 | -26.68% |
| 2013 | $0.41 | -5,911.27% |
| 2012 | $-0.01 | -101.66% |
| 2011 | $0.43 | -0.14% |
| 2010 | $0.43 | 171.27% |
| 2009 | $0.16 | -73.69% |
| 2008 | $0.60 | -128.28% |
| 2007 | $-2.12 | 0.05% |
| 2006 | $-2.12 | -409.12% |
| 2005 | $0.69 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | 872.91% |
US
|
|
| $3.19 | 2.51% |
DE
|
|
| $34.71 | 1,015.61% |
US
|
|
| $1.90 | -38.86% |
SA
|
|
| $0.29 | -90.74% |
CN
|
Questions about Clínica Baviera, S.A.'s earnings per share (EPS)
What is Clínica Baviera, S.A.'s earnings per share (EPS)?
Clínica Baviera, S.A.'s earnings per share (EPS) over the last twelve months is $3.11, as of Jun 2026.
What was Clínica Baviera, S.A.'s earnings per share (EPS) in 2025?
In 2025, Clínica Baviera, S.A.'s earnings per share (EPS) was $3.09, 20.23% more than in 2024 ($2.57).
How has Clínica Baviera, S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Clínica Baviera, S.A.'s earnings per share (EPS) went from $1.05 to $3.09, an average growth of 24.09% a year.
How does Clínica Baviera, S.A.'s earnings per share (EPS) compare with similar companies?
Clínica Baviera, S.A.'s earnings per share (EPS) ($3.11) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.